ArticleMolecular cancer research : MCR2019

Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination.

Satoshi Washino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.